Study on the Effectiveness and Safety of Shuxinin Injection in the Treatment of Acute Ischemic Stroke
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 480 participants.
Also called NCT04950790
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 480 participants
- Registry
-
NCT04950790
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT04950790. Randomized; double masking; primary purpose treatment. Start 2018-04-01 (actual); primary completion 2021-12-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study on the Effectiveness and Safety of Shuxinin Injection in the Treatment of Acute Ischemic Stroke
- Condition
- Acute Ischemic Stroke
- Intervention (Drug)
- Shuxinin injection
- Intervention (Drug)
- Basic treatment
- Intervention (Drug)
- Placebo
- Lead sponsor
- Peking University Third Hospital
- Collaborator
- Handan Central Hospital
Record details
- Record id
cardio:ct-nct04950790- Content hash
9e0540fda73cac2f120453ae0b6c74973c6a87fb991ec0e7472785e5ff4726e1